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As an alternative to automated extraction, fecal specimens were processed by investigational lysis/heating (i.e., manual) and by
chromatography/centrifugation (i.e., column) methods. ProGastro SSC and Shiga toxin-producing Escherichia coli (i.e., STEC)
indeterminate rates for 101 specimens were 1.0% to 3.0% for automated, 11.9% for manual, and 24.8% to 37.6% for column
methods. Following freeze-thaw of 247 specimens, indeterminate rates were 1.6% to 2.4% for manual and 0.8 to 5.3% for column
methods. Mean processing times for manual and columnmethods were 30.5 and 69.2 min, respectively. Concordance of investi-
gational methods with automated extraction was>98.8%.
Accurate and rapid laboratory diagnostics for patientswith gas-troenteritis contribute to clinical management and expedient
public health notification (1). Molecular-based assays have dem-
onstrated reliable identification of common bacterial agents of
gastrointestinal disease (2–6), yet performance of these assaysmay
present obstacles for laboratories not possessing automated
means of nucleic acid extraction and workflow challenges for
other laboratories. Development of alternative processing proto-
cols must ensure mitigation of inhibitory agents endogenous to
fecal specimens (7, 8) and of those produced by commensal en-
teric Gram-negative bacteria (9).
ProGastro SSCS (Hologic, San Diego, CA) is an FDA-cleared
multiplex real-time PCR assay for qualitative detection of nucleic
acid specific to Salmonella spp., Shigella spp., Campylobacter coli/
Campylobacter jejuni (undifferentiated), and Shiga toxin-produc-
ing Escherichia coli (STEC). The assay is indicated on preserved
fecal specimens from symptomatic patients with signs and symp-
toms of gastroenteritis. Furthermore, performance of PCR is to be
preceded by nucleic acid extraction using either of two automated
platforms (10). Compared to conventional culture/enzyme im-
munoassaymodalities, and pairedwith a bidirectional sequencing
adjudicator, the assay demonstrated 100% accuracy in detection
of these nucleic acids from preserved fecal specimens (6). Valid
results were procured at a rate of 98.8% using NucliSens easyMag
system (bioMérieux) automated extraction.
One commercial molecular assay for another gastrointestinal
pathogen,Clostridium difficile, utilizes facets of manual extraction
paradigms described by Boom et al. (11). Importantly, glass par-
ticles were found to bind nucleic acids in the context of crude
cellular lysates. Previous data describe efficientmanual processing
protocols for molecular detection of toxigenic C. difficile with
rapid turnaround time (12). Moreover, quality assurance data re-
vealed a 0.51%molecularC. difficile indeterminate rate (indicative
of insufficient internal control amplification) from 10,131 pri-
mary specimens tested over 3 years (Wheaton Franciscan Labora-
tory, unpublished findings). The objective of this study was to
investigate application of off-label, nonautomated extraction pro-
tocols, including methods previously described by Boom et al.
(11), to clinical performance of ProGastro SSCS. (Results of this
work were presented in part at the 115th General Meeting of the
American Society forMicrobiology,NewOrleans, LA, 30May to 2
June 2015.)
A Wheaton Franciscan healthcare institutional review board–
approved study protocol is outlined in Figure 1. Primary diarrheal
specimens submitted as part of routine care were preserved in
Cary Blair transport medium (Meridian Biosciences, Cincinnati,
OH). NucliSens easyMag extractions (referred to as automated
method) were performed by an outside laboratory per package
insert instructions, beginningwith 50l of preserved stool diluted
in 450 l of Cary Blair transport medium plus 10 l of additive
ProGastro SSCS-provided internal control nucleic acid. Alterna-
tively, QIAamp fast DNA stool minikit (Qiagen, Alameda, CA)
extractions (referred to as column method) were prepared per
manufacturer guidelines for pathogen detection (13) using ap-
proximately 180 mg of preserved stool with 1.0 ml of InhibitEx
buffer and 10 l of additive internal control nucleic acid. Nucleic
acid extracts from these two protocols were frozen at70°C prior
to PCR analysis. In addition, specimens were subjected to a lysis-
and glass bead-based preparation (referred to asmanualmethod).
In brief, 200 l of preserved stool was diluted with 200 l of
Tris-HCl buffer (BD lysis kit; BD Diagnostics, Sainte-Foy, Que-
bec) in 2.0-ml polypropylene screw-cap microcentrifuge tubes
(Corning Life Sciences, Corning, NY) and then was vortexed for 1
min. Then, 10 l of the suspension was transferred to lysis tubes
containing glass beads alongwith additive 40l of Tris-HCl buffer
and 10 l of internal control nucleic acid. Suspensions were vor-
texed for 5min, pulse-centrifuged (14,800 rpm, 10 s), heated for 6
min at 95°C, and then frozen at70°C. Equal-volume Cary Blair
medium was substituted for preserved fecal specimen in one tube
per extraction batch as a negative extraction control (referred to as
Cary Blair aliquots) and subjugated to all aforementioned steps.
Following one freeze-thaw cycle, individual extracts and cellu-
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lar lysates (pulse-centrifuged for 10 s) were incubated in both
STEC (detection of internal control sequence and nucleic acids
specific to E. coli Shiga toxin) and SSC (detection of internal con-
trol sequence plus nucleic acids specific to Salmonella spp., Shi-
gella spp., and C. coli/C. jejuni) master mixes as components of
ProGastro SSCS (10). Per package insert specifications, the max-
imum cycle threshold (CT) value yielding a valid internal control
nucleic acid amplification result on both SSC and STEC master
mixes was 45.0.
Efficacy of extraction modalities for amplification of internal
control was assessed in the context of 101 clinical specimens (re-
ferred to as Cary Blair stool) and 16 Cary Blair aliquots. Of the 702
total results generated by the three extraction modalities distrib-
uted among SSC and STEC master mixes, 124 (17.7%) were ini-
tially discordant, with 117 of these being indeterminate (Table 1).
Anunacceptable percentage of indeterminate SSC resultswas gen-
erated followingmanual (11.9%) and column (24.8%) extractions
of Cary Blair stool (P 0.016 versus automated).When themean
CT values of specimens that did yield valid results for all three
extraction modalities were compared, less internal control ampli-
con was generated by column (P  0.0001 versus manual) and
manual (P 0.0001 versus automated) methods. Moreover, 75%
of Cary Blair aliquots failed to generate a valid result via column
extraction, with decreased internal control amplification (CT,
40.05; P 0.013 versus automated and manual). Similar findings
resulted from incubation of automated, manual, and column ex-
tracts/lysates with the STEC master mix.
As studies have espoused the value of a freeze-thaw cycle for
removal of endogenous inhibitors from primary specimens (14–
16), extractions were subsequently processed following storage of
247 Cary Blair stools and 39 Cary Blair aliquots overnight at
70°C. The 101 previously assessed Cary Blair stools (Table 1)
were a component of this study set. Of the 1,716 total results
generated by the three extraction modalities distributed among
SSC and STEC master mixes, just 58 (3.4%) were initially discor-
dant, with 47 of these being indeterminate (Table 2). Valid Cary
Blair stool results were generated from SSCmaster mix at a rate of
98.4% after automated, manual, and column extraction (P 
0.41). Both automated and manual extraction allowed for suffi-
cient internal control amplification from Cary Blair stool and
Cary Blair aliquots (CT,34.82; P 0.22 for intermodality com-
parisons). An unacceptable indeterminate result rate from Cary
Blair aliquots remained for column extraction (20.5%), while in-
ternal control amplification was less efficient (CT, 39.67; P 
0.0001 versus automated and manual). Also, 5.3% and 28.2% of
Cary Blair stool and Cary Blair aliquot STEC master mix results,
respectively, derived from column extraction were indeterminate.
Internal control amplificationwas less robust than automated and
manual extraction (P 0.0001).Manual extraction of clinical and
control material exhibited similar performance to automated ex-
FIG 1 Study algorithm.
TABLE 1 Characterization of initial ProGastro SSCS results derived from three extraction modalities on 101 Cary Blair-preserved stool specimens
and 16 Cary Blair aliquots without antecedent freeze-thaw cycle
Extraction
modality
SSC master mix STEC master mix
Cary Blair stool
Cary Blair aliquots (negative
control) Cary Blair stool


































Automated 3 (3.0) 34.93 0 (0.0) 35.43 1 (1.0) 34.21 0 (0.0) 35.40b
Manual 12 (11.9) 36.55 0 (0.0) 35.60 12 (11.9) 35.90 1 (6.3) 35.00
Column 25 (24.8) 38.42 12 (75.0) 40.05 38 (37.6) 38.49 13 (81.3) 37.70
a Provided for specimens yielding detectable internal control amplification with all three extraction modalities.
b Differences between automated, manual, and column (P 0.54).
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traction (P  0.06), with an increase in internal control amplifi-
cation efficiency (P 0.03).
Initially discordant results derived from extractions of freeze-
thawed Cary Blair stool and Cary Blair aliquots were adjudicated
by repeat PCR performance on the frozen extracts/lysates. Twelve
of 47 indeterminate results could not be resolved (n 4, manual
extraction; n  8, column extraction). Performance indices of
manual and column modalities (91.7% sensitivity, 99.6%
specificity) rivaled those of reference automated extraction in this
study set that yielded 15 Salmonella spp., 12 Shigella spp., 16 C.
coli/C. jejuni, and 8 Shiga toxin-producing E. coli by SSC and
STEC master mixes (Table 3). While this investigation was not
designed to examine the sensitivity of ProGastro SSCS compared
to reference methods, such as culture and enzyme immunoassay
(6), 36.4%, 16.7%, and 7.7% more instances of C. coli/C. jejuni,
Shigella spp., and Salmonella spp., respectively, were detected via
manual extraction than by culture (data not illustrated). Final
concordance rates of manual and columnmethods with the auto-
mated reference were 98.8% and 99.2%, respectively.
In design of themanual protocol, the 1:10 dilution alignedwith
package insert specifications relative to automated extraction.
Furthermore, Monteiro et al. (17) described the performance of
Helicobacter pylori PCR using an initial stool dilution of 1:10.
Amendment of the column protocol (performed at an approxi-
mate 1:7 dilution) to allow for an initial 1:10 Cary Blair stool or
Cary Blair aliquot dilution may be warranted in further studies to
determine if rates of initially indeterminate results can be de-
creased to the level of the manual method. In our evaluation, the
initial dilution was accomplished with consecutive 1:2 and 1:5
dilutions to allow for a larger sampling of Cary Bair stool. Despite
the increased labor, mean processing time for manual extraction
of a 7-specimen batch (30.5 min) was less than both the column
method (69.2 min; P 0.0001) and the automated reference (60
min; independent laboratory, personal communication). These
data do not consider the time necessary to execute the freeze-thaw
cycle itself. However, these components can easily be managed by
laboratory support personnel as the preserved specimen arrives in
the laboratory and by a technologist as part of the routine testing
workload.
Similar to other PCR (12, 18, 19) and reverse transcriptase PCR
(14) assays, additional workflow optimization of ProGastro SSCS
can be accomplished by utilization of batch-prepared frozenmas-
ter mix tubes (20). In summary, exposure of Cary Blair stool and
medium aliquots to a single freeze-thaw cycle accommodates off-
label nucleic acid extraction for accurate performance of Pro-
Gastro SSCS. This modification, particularly in the context of an
efficient lysis protocol, may expand opportunities for laboratories
to contribute to the rapid diagnosis of bacterial gastroenteritis.
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